Area of expertise and Healthcare Provider’s contribution to care for patients within the MetabERN Network
Barcelona, SPAIN
Area of expertise and Healthcare Provider’s contribution to care for patients within the MetabERN Network
Hospital Universitario Vall d’Hebron is a health care institution within the Catalan public health care system, one of the foremost health care complexes in Spain, with 1072 beds, a University and a Research Center. It’s a National Reference Center for most diseases and participates in more than 10 ERNs.
Vall d’Hebron University Hospital is one of the main training centres in the whole of Spain, accepting rotations of external residents, as well as offerings fixed support for the accreditation of some specialities in areas of great complexity.
Vall d’Hebron Research Institute (VHIR) is one of the most active Health Research Institutes (IIS) in Spain with 1200 researchers, 330 research projects and 877 ongoing clinical trials.
Our Metabolic Unit is a National Reference Center for Metabolic diseases for children and adults. We follow patients from the first days of life to elder ages, with a multidisciplinary team specific for the disease and necessities and a well-established transition program. We receive patients from all our country having the largest cohort of patients with Lysosomal Disorders in Spain.
Our Unit is in close contact with patient associations working together on many projects (educational, research). In the last years, we have developed a special dedication to lysosomal diseases.
Our centre participates in the Newborn Screening program in Catalunya which covers 21 treatable diseases and participates in International Metabolic Networks.
We dispose of high complexity treatments and participate in several clinical trials in different metabolic diseases with public and private partnerships.
Our professionals organize and participate as teachers in academic courses, Masters in Metabolic disorders and national and international meetings.
Our center offers diagnosis and treatment for the majority of treatable metabolic disorders, with a patient centered organitation.